The advancements in cardiovascular regenerative medicine are reshaping therapeutic strategies for heart diseases by promoting tissue repair and regeneration. This innovative field leverages technologies such as induced pluripotent stem cells and growth factor delivery to restore the heart’s structural and functional integrity. Bioengineered scaffolds and 3D bioprinting are also being utilized to reconstruct damaged myocardium and improve vascularization. Researchers are further exploring the role of exosomes and microRNAs in enhancing the heart’s natural regenerative processes. With ongoing clinical trials and interdisciplinary collaboration, cardiovascular regenerative medicine holds immense potential to provide long-term solutions for conditions like ischemic heart disease and heart failure, moving beyond traditional treatments toward curative approaches.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Therapeutic pneumoperitoneum mimicking inferior myocardial infarction and right ventricular aneurysm: A case report
Abhinav Prithvi Venkata Sesha Kanigicherla, University Hospital Coventry and Warwickshire NHS Trust, United Kingdom
Title : Multisystem IgG4-related disease with cardiac involvement mimicking cardiac sarcoidosis: a diagnostic challenge background
Natasha Manuelpillai, Salisbury District Hospital- NHS, United Kingdom
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation